Announce Date | 01/29/2025 |
EPS Normalized Actual | $3.67 (Beat by $0.02) |
EPS GAAP Actual | $3.67 (Beat by $0.02) |
Revenue Actual | $2.957B |
Revenue Surprise | Beat by $2957M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $3.51527 |
EPS GAAP Estimate | $3.51527 |
Revenue Estimate | $3.153203673B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 33.49 | 23.39 | 32.74034 | 35.12945 | 1 |
Dec 2028 | 0 | INF | 0 | 0 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 1.86 | 1.86 | 2.957B | 17.59% | 2957M |
FQ3 2024 (Sep 2024) | 2.09 | 2.09 | 2.797B | 18.2% | 2797M |
FQ2 2024 (Jun 2024) | 1.27 | 1.27 | 2.627B | 18.16% | 2627M |
FQ1 2024 (Mar 2024) | 1.69 | 1.69 | 2.603B | 19.48% | 2603M |
FQ4 2023 (Dec 2023) | 1.44 | 1.44 | 2.437B | 20.39% | 2437M |
FQ3 2023 (Sep 2023) | 1.18 | 1.18 | 2.288B | 19.97% | 2288M |
FQ2 2023 (Jun 2023) | 5.12 | 5.12 | 2.15B | 100% | 2150M |
FQ1 2023 (Mar 2023) | 0.74 | 0.74 | 2.096B | 100% | 2096M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
3.51527
Consensus Revenue Estimates
3.153203673B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 6.16422 | -- | 6.11622 | 6.27208 | 19 |
FQ2 2027 (Jun 2027) | 5.28231 | -- | 5.24118 | 5.37474 | 10 |
FQ1 2027 (Mar 2027) | 5.47855 | -- | 5.43589 | 5.57442 | 13 |
FQ4 2026 (Oct 2026) | 4.99622 | -- | 4.87474 | 5.13245 | 8 |
FQ3 2026 (Jul 2026) | 4.26425 | -- | 4.16057 | 4.38052 | 9 |
FQ2 2026 (Jun 2026) | 4.3079 | -- | 4.13733 | 4.41738 | 17 |
FQ1 2026 (Mar 2026) | 4.61127 | -- | 4.42869 | 4.72846 | 8 |
FQ4 2025 (Oct 2025) | 4.13813 | 55.05 | 4.03752 | 4.25096 | 12 |
FQ3 2025 (Jul 2025) | 3.55235 | 41.17 | 3.46598 | 3.64921 | 9 |
FQ2 2025 (Jun 2025) | 3.51527 | 63.87 | 3.37608 | 3.60461 | 12 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 4.73B | -- | 4.7B | 4.79B | 20 |
FQ2 2027 (Jun 2027) | 4.43B | -- | 4.4B | 4.48B | 11 |
FQ1 2027 (Mar 2027) | 4.36B | -- | 4.34B | 4.42B | 14 |
FQ4 2026 (Oct 2026) | 3.95B | -- | 3.88B | 4.04B | 10 |
FQ3 2026 (Jul 2026) | 3.75B | -- | 3.68B | 3.83B | 10 |
FQ2 2026 (Jun 2026) | 3.77B | -- | 3.65B | 3.84B | 10 |
FQ1 2026 (Mar 2026) | 3.72B | -- | 3.61B | 3.79B | 10 |
FQ4 2025 (Oct 2025) | 3.31B | 10.77 | 3.25B | 3.38B | 9 |
FQ3 2025 (Jul 2025) | 3.15B | 11.08 | 3.09B | 3.21B | 9 |
FQ2 2025 (Jun 2025) | 3.15B | 16.69 | 3.06B | 3.21B | 9 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 1.86 | 1.86 | 100% | |
FQ3 2024 (Sep 2024) | 2.09 | 2.09 | 100% | |
FQ2 2024 (Jun 2024) | 1.27 | 1.27 | 100% | |
FQ1 2024 (Mar 2024) | 1.69 | 1.69 | 100% | |
FQ4 2023 (Dec 2023) | 1.44 | 1.44 | 100% | |
FQ3 2023 (Sep 2023) | 1.18 | 1.18 | 100% | |
FQ2 2023 (Jun 2023) | 5.12 | 5.12 | 100% | |
FQ1 2023 (Mar 2023) | 0.74 | 0.74 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $2.96B | $2957M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.8B | $2797M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.63B | $2627M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.6B | $2603M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.44B | $2437M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.29B | $2288M | 100% |
FQ2 2023 (Jun 2023) | $0B | $2.15B | $2150M | 100% |
FQ1 2023 (Mar 2023) | $0B | $2.1B | $2096M | 100% |